# Study to Evaluate the Efficacy and Safety of Aripiprazole

> **NCT02069977** · PHASE4 · UNKNOWN · sponsor: **Yoo-Sook Joung** · enrollment: 79 (estimated)

## Conditions studied

- Autism

## Interventions

- **DRUG:** Aripiprazole

## Key facts

- **NCT ID:** NCT02069977
- **Lead sponsor:** Yoo-Sook Joung
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 79 (ESTIMATED)
- **Last updated:** 2014-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02069977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02069977, "Study to Evaluate the Efficacy and Safety of Aripiprazole". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT02069977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*